Skip to main content
Home
TERUMO GLOBAL

Select Region

Show — Select Region Hide — Select Region
    • Regions/Countries
        • Japan
        • United States
            • Terumo Interventional Systems
            • Terumo Cardiovascular
            • MicroVention (Neurovascular)
            • Terumo Blood and Cell Technologies
            • Terumo Aortic
            • Terumo Medical Products
            • Terumo Medical Corp
            • Terumo Health Outcomes
        • Canada
        • Europe
        • Latin America
            • Mexico
            • Brazil
            • Colombia
            • Chile and Argentina
        • Asia Pacific
        • Australia
        • Korea
        • Vietnam
        • China
        • India
    • Global Business website
        • Terumo Cardiovascular
        • Terumo Aortic
        • MicroVention (Neurovascular)
        • Terumo Blood and Cell Technologies
        • Pharmaceutical Solutions
  • About Terumo
    About Terumo
      • Dear Stakeholders
      • Who We Are
      • Corporate Governance
      • Compliance
      • Regulations and Standards
      • Procurement Activity
      • At a Glance
      • Terumo Group Identity
      • Leadership Team
      • History
      • TERUMO’s Purpose
      • Terumo's Response to COVID-19
  • Business Overview
    Business Overview
      • TIS Division (Terumo Interventional Systems)
      • Neurovascular Division (MicroVention)
      • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
      • Vascular Graft Division (Terumo Aortic)
      • Hospital Care Solutions Division
      • Life Care Solutions Division
      • Pharmaceutical Solutions Division
      • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
  • Sustainability
    Sustainability
      • Sustainability News
      • Message from Top Management
      • Sustainability at the Terumo Group
      • Resolving Healthcare Challenges
      • Creating a Diverse and Inclusive Workplace
      • Reducing Environmental Footprint
      • Serving Our Communities
      • Report Library
      • GRI Standards Index
  • Technology
    Technology
      • From Devices to Solutions
      • Basic Information
          • Basic Information Top
          • Research and Development
          • Production and Supply
          • Intellectual Property
          • Terumo Fellows
      • Stories - Our Technologies
  • Investors
    Investors
      • Management Policy
          • Management Policy
          • Top Management Message
          • Business Risks
          • Disclaimer
          • IR Policy
      • Financial Highlights
      • IR Library
          • IR Library
          • Financial Statements
          • Presentations
          • Consolidated Financial Statements
          • Terumo Reports
      • IR Events
      • Shareholders & Stock
          • Shareholders Meeting
          • Stock Information
          • Shareholder Return
          • Credit Ratings and Corporate Bond
          • Analyst Coverage
          • Articles of Incorporation
          • Site Quote
      • IR Inquiries
  • News
    News
      • May 25, 2023
        Corporate
        Terumo Blood and Cell Technologies Optimizing Cell Therapy Production Through Industry’s First Apheresis Training for Cell Therapy Manufacturers

        Terumo Blood and Cell Technologies presents data on collection efficiency process with Spectra Optia® Apheresis System at major conferences

      • May 15, 2023
        Corporate
        Terumo to Construct a New Manufacturing Facility at its Kofu Factory for the Medical Care Solutions Company

        52.2 Billion JPY Capital Investment to Strengthen the Production Capability to Meet the Growing Global Demands

      • May 15, 2023
        Corporate
        Terumo Appoints the Candidates for Directors (PDF 96.39 KB)
    • Global Network
      Global Network
        • Japan
        • North America
        • South America
        • Europe, Middle East and Africa
        • Greater China
        • Asia and Pacific

    Breadcrumb

    1. Home
    2. Investors
    3. IR Library
    4. Consolidated Financial Statements

    Consolidated Financial Statements

    Move to topTop
    • FYE 3/2022
    • FYE 3/2020
    • FYE 3/2019
    • FYE 3/2018
    • FYE 3/2017
    • FYE 3/2022

      Consolidated Financial Statements (PDF 1.19 MB)
      Consolidated Financial Statements (PDF 1.19 MB)
    • FYE 3/2020

      Consolidated Financial Statements (PDF 1.48 MB)
    • FYE 3/2019

      Consolidated Financial Statements (PDF 1.52 MB)
    • FYE 3/2018

      Consolidated Financial Statements (PDF 1.77 MB)
    • FYE 3/2017

      Consolidated Financial Statements (PDF 2.93 MB)
    Adobe Acrobat Reader

    Adobe Reader (free) is required to view PDF files.

    Download Adobe Reader

    Footer Menu

    Show — Footer Menu Hide — Footer Menu
      • About Terumo
          • About Terumo
          • Dear Stakeholders
          • Who We Are
          • Corporate Governance
          • Compliance
          • Regulations and Standards
          • Procurement Activity
          • At a Glance
          • Terumo Group Identity
          • Leadership Team
          • History
          • TERUMO’s Purpose
          • Terumo's Response to COVID-19
      • Business Overview
          • Business Overview
          • TIS Division (Terumo Interventional Systems)
          • Neurovascular Division (MicroVention)
          • Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division
          • Vascular Graft Division (Terumo Aortic)
          • Hospital Care Solutions Division
          • Life Care Solutions Division
          • Pharmaceutical Solutions Division
          • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
      • Sustainability
          • Sustainability Overview
          • Sustainability News
          • Message from Top Management
          • Sustainability at the Terumo Group
          • Resolving Healthcare Challenges
          • Creating a Diverse and Inclusive Workplace
          • Reducing Environmental Footprint
          • Serving Our Communities
          • Report Library
          • GRI Standards Index
      • Technology
          • From Devices to Solutions
          • Technology Overview
          • Basic Information
              • Research and Development
              • Production and Supply
              • Intellectual Property
              • Terumo Fellows
          • Stories - Our Technologies
      • Investors
          • Investors
          • Management Policy
              • Top Management Message
              • Business Risks
              • Disclaimer
              • IR Policy
          • Financial Highlights
          • IR Library
              • Financial Statements
              • Presentations
              • Consolidated Financial Statements
              • Terumo Reports
          • IR Events
          • Shareholders & Stock
              • Shareholders Meeting
              • Stock Information
              • Shareholder Return
              • Credit Ratings and Corporate Bond
              • Analyst Coverage
              • Articles of Incorporation
              • Site Quote
          • IR Inquiries
      • News
          • News
          • Press Inquiries
      • Global Network
          • Japan
          • North America
          • South America
          • Europe, Middle East and Africa
          • Greater China
          • Asia and Pacific
    • About Terumo
    • Business Overview
    • Sustainability
    • Technology
    • Investors
    • News
    • Global Network

    Footer

    Show — Footer Hide — Footer
    • Terms and Conditions of Use
    • Privacy Policy
    • Cookie Policy
    • Cookie Settings
    • Social Media Policy
    • Site Map

    Copyright © 2023 Terumo Corporation, All Rights Reserved.